Bardavon Health Innovations Secures $90 Million In Series C Funding To Advance True Msk Technology Platform Beyond Workers’ Compensation Care
Bardavon Health Innovations Secures $90 Million In Series C Funding To Advance True Msk Technology Platform Beyond Workers’ Compensation Care
10/20/21, 11:16 AM
Location
overland parkMoney raised
$90 million
Industry
sports
mobile
health care
commerce and shopping
Round Type
series c
Bardavon Health Innovations, a Workers’ Compensation and musculoskeletal (MSK) health company, announced a Series C funding of $90 million led by investor Matrix Capital Management, a public and private investment firm, joined by WestCap, a growth equity firm.
Company Info
Location
overland park, kansas, united states
Additional Info
The company currently has over 220 employees. Bardavon will use the investment to accelerate go to market activities, expand capabilities, and introduce new offerings and services to all payer classes. About Bardavon Health Innovations Bardavon is a privately held proactive Workers’ Compensation and MSK digital health partner that connects all stakeholders to better manage claims.